Some index variants such as those at the cyclin-dependent kinase inhibitor 2A/cyclin-dependent kinase inhibitor 2B (CDKN2A/CDKN2B) gene on 9p21 have been validated to confer CAD risk in multiple ethnic groups4–7. This evidence concerns the gene CDKN2A and coronary artery disorder.